Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.
Last reviewed: May 31, 2026
Next scheduled review: June 30, 2026
Reviewed by: Dr. Sam Saberian, Lead Medical Researcher
Edited by: Julliana Edwards, Editor
Methodology: GLP-1 Editorial v3.0 rubric
Compounded GLP-1 provider

Noom Med

Semaglutide + Tirzepatide
Noom Med compounded semaglutide + tirzepatide injection vial — editorial illustration
Provider Review · 70/100 · Updated 2026-05-08

Noom Med Review

Behavioral-program-led brand telehealth. Single pillar met. Strongest fit for users already in the Noom ecosystem.

#10 of 1070/100$199/mo
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Overview

Behavioral-program-led brand telehealth. Single pillar met. Strongest fit for users already in the Noom ecosystem.

Noom Med at a glance

Editorial rank
#10 of 10
Score
70/100 · 3.5/5 stars
Pillars met
1 of 6
Pricing
$199/mo
Pharmacy model
Brand (insurance)
Clinical model
Brand + behavioral

Six-pillar scoring

Noom Med meets 1 of 6 v3.0 transparency pillars. Single pillar met typically reflects a published clinical protocol but limited disclosure on pharmacy traceability, cohort outcomes, or pricing structure.

Pricing

$199/mo. Verify final pricing directly with the provider before purchasing — prices may change.

Trade-offs to know

How to evaluate Noom Med

If you're considering Noom Med, verify directly: (1) named Medical Director and state licensure, (2) the dispensing pharmacy on every shipment label, (3) whether per-batch CoAs (USP <71>, USP <85>, HPLC potency) are available on request, (4) the full out-of-pocket monthly cost across the titration schedule, (5) the FDA-approval status of any medication you're prescribed.

Visit Noom Med →

Important medical and regulatory disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.